演变的SARS-CoV-2疫苗:从当前的解决方案到广谱保护
Rui Qiao1,2, Jiayan Li2, Jiami Gong2
1Shanghai Sci-Tech Inno Center for Infection & Immunity, National Medical Center for Infectious Diseases, Huashan Hospital, Institute of Infection and Health, Fudan University, Shanghai 200438, China.
严重急性呼吸道综合征冠状病毒2 (SARS-CoV-2) 的持续演变需要适应性疫苗. 新的疫苗策略旨在对SARS-CoV-2变种和其他sarbecoviruses提供广泛的保护.
科学领域:
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
背景情况:
- 严重急性呼吸道综合征冠状病毒2 (SARS-CoV-2) 持续演变,导致令人担忧的变种 (VOC).
- 病毒突变增强了感染力,促进了免疫逃避,并降低了疫苗的有效性.
- 其他沙尔贝科病毒,如SARS-CoV-1,构成未来的流行病风险.
研究的目的:
- 审查当前的SARS-CoV-2疫苗策略和目标抗原.
- 总结开发针对新出现的SARS-CoV-2变种疫苗的方法.
- 探索开发针对多种沙贝科病毒有效的广谱疫苗.
主要方法:
- 关于SARS-CoV-2和sarbecovirus疫苗的当前科学文献的审查.
- 对疫苗平台的分析,包括非活化,病毒载体和核酸疫苗.
- 检查免疫逃避策略和抗原点.
主要成果:
- 目前的疫苗面临来自新出现的SARS-CoV-2变种的挑战.
- 正在研究创新的疫苗平台,以寻找宽频中和抗体反应.
- 目前正在进行研究,以开发针对传染性沙贝科病毒的疫苗.
结论:
- 疫苗适应和广谱保护对于控制流行病至关重要.
- 开发针对SARS-CoV-2变种和其他sarbecoviruses有效的疫苗是必要的.
- 需要对新型疫苗平台进行进一步研究,以应对当前和未来的威胁.
更多相关视频
12:09Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection
Published on: May 2, 2011
10:58Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
Published on: August 21, 2019
相关概念视频
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cross-reactivity
Vaccinations
Microorganisms in Medicine and Therapeutics
Viral Mutations
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
